Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
11.57
+0.07 (0.61%)
At close: Dec 20, 2024, 4:00 PM
11.56
-0.01 (-0.10%)
After-hours: Dec 20, 2024, 5:27 PM EST
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $8.42 billion as of December 20, 2024. Its market cap has increased by 7.45% in one year.
Market Cap
8.42B
Enterprise Value
3.09B
1-Year Change
7.45%
Ranking
Category
Stock Price
$11.57
Market Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $8.42B, an increase of 1,479.07%. That is a compound annual growth rate of 98.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 8.42B | -6.71% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | 521.58M | -2.21% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio-Rad Laboratories | 9.09B |
| Bio-Rad Laboratories | 9.08B |
| Masimo | 9.04B |
| Intra-Cellular Therapies | 8.87B |
| Henry Schein | 8.57B |
| Bruker | 8.37B |
| Ascendis Pharma | 8.25B |
| HealthEquity | 8.21B |